Molecular biology of the hepatitis B virus and role of the X gene;Biologie moléculaire du virus de l'hépatite B et rôle du gène X

Pathologie Biologie

Volumn 58, Issue 4, 2010, Pages 267-272

  Wei, Y ^a   Neuveut, C ^a   Tiollais, P ^a   Buendia, M A ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Cancer; HBV; HBx; Hepatitis; Replication; Transcription; Virus

Indexed keywords

BECLIN 1; CIRCULAR DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA POLYMERASE; GENOMIC RNA; HEPATITIS B ANTIGEN; HEPATITIS B VIRUS X PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLO LIKE KINASE 1; PROTEIN TYROSINE KINASE; RAS PROTEIN; RNA DIRECTED DNA POLYMERASE; TRANSCRIPTION FACTOR NFAT; UBIQUITIN PROTEIN LIGASE E3; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; DNA SYNTHESIS; ENZYME ACTIVITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PLEIOTROPY; PROTEIN INTERACTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS CAPSID; VIRUS REPLICATION;

DNA, VIRAL; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 77955425644     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2010.03.005     Document Type: Article

References (69)

1. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-3044.
2. Cougot D., Neuveut C., Buendia M.A. HBV induced carcinogenesis. J Clin Virol 2005, 34:S75-S78.
3. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 1978, 24:40-69.
4. Blumberg B.S., Alter H.J., Visnich S. A "new" antigen in leukemia sera. JAMA 1965, 191:541-546.
5. Bayer M.E., Blumberg B.S., Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia. Down's Syndrome and hepatitis. Nature 1968, 218:1057-1059.
6. Robinson W.S., Clayton D.A., Greenman R.L. DNA of a human hepatitis B virus candidate. J Virol 1974, 14:384-391.
7. Fritsch A, Pourcel C, Charnay P, Tiollais P. Clonage du génome du virus de l'hépatite B dans Escherichia coli. C R Acad Sci Paris 1978;287(Série D):1453-56.
8. Charnay P., Pourcel C., Louise A., Fritsch A., Tiollais P. Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A 1979, 76:2222-2226.
9. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979, 281:646-650.
10. Sninsky J.J., Siddiqui A., Robinson W.S., Cohen S.N. Cloning and endonuclease mapping of the hepatitis B viral genome. Nature 1979, 279:346-348.
11. Summers J., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982, 29:403-415.
12. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature 1985, 317:489-495.
13. Michel M.L., Pontisso P., Sobzack E., Malpièce Y., Streeck R.E., Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A 1984, 81:7708-7712.
14. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26:6266-6273.
15. Chang M.H., You S.L., Chen C.J., Liu C.J., Lee C.M., Lin S.M., et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009, 101:1348-1355.
16. Seitz S., Urban S., Antoni C., Bottcher B. Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 2007, 26:4160-4167.
17. Dejean A., Sonigo P., Wain-Hobson S., Tiollais P. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11 base pair direct repeat. Proc Natl Acad Sci U S A 1984, 81:5350-5354.
18. Soussan P., Garreau F., Zylberberg H., Ferray C., Brechot C., Kremsdorf D. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 2000, 105:55-60.
19. Lepère-Douard C., Trotard M., Le Seyec J., Gripon P. The first transmembrane domain of the hepatitis B virus large envelope protein is crucial for infectivity. J Virol 2009, 83:11819-11829.
20. Schulze A., Schieck A., Ni Y., Mier W., Urban S. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol 2010, 84:1989-2000.
21. Weiser B., Ganem D., Seeger C., Varmus H.E. Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol 1983, 48:1-9.
22. Beck J., Nassal M., Hepatitis B virus replication. World J Gastroenterol 2007, 13:48-64.
23. Sohn J.A., Litwin S., Seeger C. Mechanism for CCC DNA synthesis in hepadnaviruses. PLoS One 2009, 4:e8093.
24. Newbold J.E., Xin H., Tencza M., Sherman G., Dean J., Bowden S., et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 1995, 69:3350-3357.
25. Cattaneo R., Will H., Schaller H., Hepatitis B virus transcription in the infected liver. EMBO J 1984, 3:2191-2196.
26. Möröy T., Etiemble J., Trépo C., Tiollais P., Buendia M.A. Transcription of woodchuck hepatitis virus in the chronically infected liver. EMBO J 1985, 4:1507-1514.
27. Enders G.H., Ganem D., Varmus H. Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant. Cell 1985, 42:297-308.
28. Shaul Y., Rutter W.J., Laub O. A human hepatitis B viral enhancer element. EMBO J 1985, 4:427-430.
29. Siddiqui A., Jameel S., Mapoles J.E. Transcriptional control elements of hepatitis B surface antigen gene 1986, 83:566-570.
30. Doitsh G., Shaul Y., Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol 2004, 24:1799-1808.
31. Pollicino T., Belloni L., Raffa G., Pediconi N., Squadrito G., Raimondo G., et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006, 130:823-837.
32. Toh H., Hyashida H., Miyata T. Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus. Nature 1983, 305:827-829.
33. Bartenschlager R., Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992, 11:3413-3420.
34. Wang G.H., Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 1992, 71:663-670.
35. Melegari M., Wolf S.K., Schneider R.J., Jung M.C., Schneider R., Santantonio T., et al. Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol 2005, 79:9810-9820.
36. Bruss V., Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991, 88:1059-1063.
37. Bruss V. Hepatitis B virus morphogenesis. World J Gastroenterol 2007, 13:65-73.
38. Summers J., Smith P.M., Huang M.J., Yu M.S. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 1991, 65:1310-1317.
39. Lenhoff R.J., Summers J. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol 1994, 68:5706-5713.
40. Robek M.D., Boyd B.S., Wieland S.F., Chisari F.V. Signal transduction pathways that inhibit hepatitis B virus replication. Proc Natl Acad Sci U S A 2004, 101:1747-1757.
41. Su Q., Schrôder C.H., Hofman W.J., Otto G., Pichlmayr R., Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinoma. Hepatology 1998, 27:1109-1120.
42. Chen H.S., Kanako S., Girones R., Anderson R.W., Hornbuckle W.E., Tennant B.C., et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993, 67:1218-1226.
43. Zoulim F., Saputelli J., Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994, 68:2026-2030.
44. Tang H., Delgermaa L., Huang F., Oishi N., Liu L., He F., et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005, 79:5548-5556.
45. Keasler V.V., Hodgson A.J., Madden C.R., Slagle B.L. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 2007, 81:2656-2662.
46. Twu J.S., Schloemer R.H. Transcriptional trans-activating function of hepatitis B virus. J Virol 1987, 61:20-30.
47. Yen B.T.S., Hepadnaviral X protein: review of recent progress. J Biomed Sci 1996, 3:20-30.
48. Barnabas S., Hai T., Andrisani O.M. The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem 1997, 272:20684-20690.
49. Cougot D., Wu Y., Cairo S., Caramel J., Renard C.A., Levy L., et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 2007, 282:4277-4287.
50. Abramovitch R., Tavor E., Jacob-Hirsch J., Zeira E., Amariglio N., Pappo O., et al. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res 2004, 64:1338-1346.
51. Andrisani O.M., Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Oncol 1999, 15:373-379.
52. Bouchard M.J., Schneider R.J. The enigmatic X gene of hepatitis B virus. J Virol 2004, 78:12725-12734.
53. Tang H., Oishi N., Kaneko S., Murakami S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 2006, 97:977-983.
54. Terradillos O., Pollicino T., Lecoeur H., Tripodi M., Gougeon M.L., Tiollais P., et al. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998, 17:2115-2123.
55. Yamada T., Yamaoka S., Goto T., Tsujimoto Y., Hatanaka M. The human leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J Virol 1994, 68:3374-3379.
56. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczac H., et al. Sensitization of T cells to CD95-mediated apoptosis by HIV1 Tat and gp 120. Nature 1995, 375:497-500.
57. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J 1997, 16:504-514.
58. Teodoro J.G., Branton P.E. Regulation of apoptosis by viral gene products. J Virol 1997, 71:1739-1746.
59. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
60. Tang H., Da L., Mao Y., Li Y., Li D., Xu Z., et al. B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology 2009, 49:60-71.
61. Sitterlin D., Bergametti F., Tiollais P., Tennant B.C., Transy C. Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 2000, 19:4427-4431.
62. Leupin O., Bontron S., Schaeffer C., Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 2005, 79:4238-4245.
63. Chu G., Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 1988, 242:564-567.
64. Lin-Marq N., Bontron S., Leupin O., Strubin M. Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein. Virology 2001, 287:266-274.
65. Martin-Lluesma S., Schaeffer C., Robert E.I., van Breugel P.C., Leupin O., Hantz O., et al. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008, 48:1467-1476.
66. Wen Y., Golubkov V.S., Strongin A.Y., Jiang W., Reed J.C. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 2008, 283:2793-2803.
67. Rakotomalala L., Studach L., Wang W.H., Gregori G., Hullinger R.L., Andrisani O., et al. B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J Biol Chem 2008, 283:28729-28740.
68. Studach L.L., Rakotomalala L., Wang W.H., Hullinger R.L., Cairo S., Buendia M.A., et al. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression. Hepatology 2009, 50:414-423.
69. Benhenda S., Cougot D., Buendia M.A., Neuveut C. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 2009, 103:75-109.